Advertisement
Advertisement
U.S. markets close in 6 hours 23 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Bureau Veritas SA (BVRDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
22.75+1.07 (+4.92%)
As of 10:56AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close21.68
Open22.50
Bid0.00 x 0
Ask0.00 x 0
Day's Range22.50 - 22.75
52 Week Range21.68 - 34.34
Volume203
Avg. Volume565
Market Cap10.362B
Beta (5Y Monthly)1.03
PE Ratio (TTM)23.95
EPS (TTM)0.95
Earnings DateN/A
Forward Dividend & Yield0.54 (2.49%)
Ex-Dividend DateJul 05, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BVRDF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BUREAU VERITAS
    Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverThis edition features BMW's transition to electric vehicles; the pricey luxury industry; a deeper look into Lumen; and notes from Lamb Weston and new coverage Rentokil Initial and Corporate Travel Management.
    Rating
    Fair Value
    Economic Moat
    11 months agoMorningstar
View more
  • GlobeNewswire

    Bureau Veritas: acquisition of Galbraith Laboratories Inc., a US expert in Healthcare analytical testing solutions

    PRESS RELEASE Neuilly-sur-Seine, France – September 19, 2022 Bureau Veritas acquires Galbraith Laboratories Inc., a US expert in Healthcare analytical testing solutions Expanding BV’s position in Consumer Healthcare, Personal Care & Industrial Chemical markets Bureau Veritas, a world leader in testing, inspection and certification, announced the acquisition of Galbraith Laboratories Inc., an expert in advanced analytical solutions in North America. The acquisition will further position Bureau Ve

  • GlobeNewswire

    Bureau Veritas: acquires a majority stake in C.A.P Government, Inc., expanding its Buildings & Infrastructure footprint in the US

    PRESS RELEASE Neuilly-sur-Seine, France – September 12, 2022 Bureau Veritas acquires a majority stake in C.A.P Government, Inc., expanding its Buildings & Infrastructure footprint in the US Bureau Veritas, a world leader in testing, inspection and certification (TIC), announced the strategic acquisition of C.A.P. Government, Inc. (CAP), a US-based company serving as one of the largest building department services firms in Florida. As the world leader in TIC for the Buildings & Infrastructure mar

  • GlobeNewswire

    Bureau Veritas: information on number of shares and voting rights

    PRESS RELEASE Neuilly-sur-Seine, France – August 22, 2022 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF DateNumber of shares(1)Number of voting rights31/07/2022454,280,554Theoretical number of voting rights: 624,239,834Number of exercisable voting rights: 622,211,565 (1) including the new shares issued in Euroclear as a result of the exercise of stock options since January 1, 2022. Bureau

Advertisement
Advertisement